These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 18363633

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
    Nielsen K, Ingvar C, Måsbäck A, Westerdahl J, Borg A, Sandberg T, Jonsson N, Nagel J, Olsson H.
    Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
    Peric B, Cerkovnik P, Novakovic S, Zgajnar J, Besic N, Hocevar M.
    BMC Med Genet; 2008 Sep 19; 9():86. PubMed ID: 18803811
    [Abstract] [Full Text] [Related]

  • 28. Important risk factors in melanoma from the Dermato-Oncologic Unit of Brescia, Italy.
    Manganoni AM, Zanotti F, Farisoglio C, Feroldi P, Facchetti F, Calzavara-Pinton P.
    Dermatol Online J; 2010 Jan 15; 16(1):17. PubMed ID: 20137759
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma.
    Stratigos AJ, Yang G, Dimisianos R, Nicolaou V, Stefanaki I, Katsambas AD, Tsao H.
    J Invest Dermatol; 2006 Feb 15; 126(2):399-401. PubMed ID: 16374456
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
    Dalmasso B, Pastorino L, Ciccarese G, Andreotti V, Grillo F, Mastracci L, Spagnolo F, Ballestrero A, Queirolo P, Bruno W, Ghiorzo P.
    J Am Acad Dermatol; 2019 May 15; 80(5):1263-1271. PubMed ID: 30274933
    [Abstract] [Full Text] [Related]

  • 33. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
    Sargen MR, Calista D, Elder DE, Massi D, Chu EY, Potrony M, Pfeiffer RM, Carrera C, Aguilera P, Alos L, Puig S, Elenitsas R, Yang XR, Tucker MA, Landi MT, Goldstein AM.
    J Am Acad Dermatol; 2020 Sep 15; 83(3):860-869. PubMed ID: 32283231
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Role of the CDKN2A locus in patients with multiple primary melanomas.
    Puig S, Malvehy J, Badenas C, Ruiz A, Jimenez D, Cuellar F, Azon A, Gonzàlez U, Castel T, Campoy A, Herrero J, Martí R, Brunet-Vidal J, Milà M.
    J Clin Oncol; 2005 May 01; 23(13):3043-51. PubMed ID: 15860862
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. High incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient.
    Sinnya S, Jagirdar K, De'Ambrosis B, McMeniman E, Sturm RA, Soyer HP.
    Arch Dermatol Res; 2015 Oct 01; 307(8):741-5. PubMed ID: 26103950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.